BUDGET IMPACT ANALYSIS OF THE CELL-BASED QUADRIVALENT INFLUENZA VACCINE IN THE GERMAN POPULATION USING A DYNAMIC TRANSMISSION MODEL APPROACH

被引：0
|
作者：
Cai, R. [1 ]
Schwehm, M. [2 ]
Joaquin, F. M. Q. [3 ]
机构：
[1] IQVIA, Amsterdam, Netherlands
[2] ExploSYS GmbH, Leinfelden Echterdingen, Germany
[3] Seqirus, Summit, NJ USA
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRS25
引用
收藏
页码：S721 / S721
页数：1
相关论文
共 50 条
  • [31] Outcomes in Pregnant Persons Immunized with a Cell-Based Quadrivalent Inactivated Influenza Vaccine: A Prospective Observational Cohort Study
    Robinson, Christopher
    Van Boxmeer, Josephine
    Tilson, Hugh
    Scialli, Anthony
    Vanchiere, John A.
    Ides, Ellis
    Sawlwin, Daphne
    Molrine, Deborah
    Hohenboken, Matthew
    Edelman, Jonathan
    Albano, Jessica D.
    [J]. VACCINES, 2022, 10 (10)
  • [32] Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model
    Deniz Schobert
    Vanessa Remy
    Oliver Schoeffski
    [J]. Health Economics Review, 2 (1)
  • [33] Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model
    Schobert, Deniz
    Remy, Vanessa
    Schoeffski, Oliver
    [J]. HEALTH ECONOMICS REVIEW, 2012, 2
  • [34] ESTIMATED HEALTH AND ECONOMIC IMPACT OF QUADRIVALENT HPV TYPES 6, 11, 16, 18 VACCINE IN THAILAND USING A TRANSMISSION DYNAMIC MODEL
    Singhal, P. K.
    Termrungruanglert, W.
    Khemapech, N.
    Havanond, P.
    Taneepanichskul, S.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A541 - A541
  • [35] ESTIMATED HEALTH AND ECONOMIC IMPACT OF QUADRIVALENT HPV TYPES 6, 11, 16, 18 VACCINE IN BRAZIL USING A TRANSMISSION DYNAMIC MODEL
    Singhal, P. K.
    Tannus, G.
    Fonseca, M.
    Kawai, K.
    Dasbach, E.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A118 - A118
  • [36] Insect Cell-Based Quadrivalent Seasonal Influenza Virus-like Particles Vaccine Elicits Potent Immune Responses in Mice
    Badruzzaman, A. T. M.
    Cheng, Yu-Chieh
    Sung, Wang-Chou
    Lee, Min-Shi
    [J]. VACCINES, 2024, 12 (06)
  • [37] Clinical and Economic Outcomes Associated with Cell-Based Quadrivalent Influenza Vaccine vs. Standard-Dose Egg-Based Quadrivalent Influenza Vaccines during the 2018-19 Influenza Season in the United States
    Krishnarajah, Girishanthy
    Divino, Victoria
    Postma, Maarten J.
    Pelton, Stephen, I
    Anupindi, Vamshi Ruthwik
    DeKoven, Mitch
    Mould-Quevedo, Joaquin
    [J]. VACCINES, 2021, 9 (02) : 1 - 17
  • [38] Modelling the population-level benefits and cost-effectiveness of cell-based quadrivalent influenza vaccine for children and adolescents aged 6 months to 17 years in the US
    Pelton, Stephen I.
    Mould-Quevedo, Joaquin F.
    Nguyen, Van Hung
    [J]. EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 82 - 87
  • [39] Cost-effectiveness of quadrivalent vaccine against human papilloma virus in Argentina based on a dynamic transmission model
    Pichon-Riviere, Andres
    Alcaraz, Andrea
    Caporale, Joaquin
    Bardach, Ariel
    Rey-Ares, Lucila
    Klein, Karen
    Calderon, Maria
    Augustovski, Federico
    Tatti, Silvio
    [J]. SALUD PUBLICA DE MEXICO, 2015, 57 (06): : 504 - 513
  • [40] PUBLIC HEALTH IMPACT OF QUADRIVALENT HPV TYPES 6, 11, 16, 18 VACCINE IN SAO PAULO, BRAZIL USING A TRANSMISSION DYNAMIC MODEL
    Singhal, P.
    Tannus, G.
    Pillsbury, M.
    Dasbach, E.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A450 - A450
12345